Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric study
CONCLUSION: In our analysis, MetS in patients with EC was not associated with impaired oncological outcome. However, our findings show that obesity itself is an important comorbidity associated with significantly reduced PFS.PMID:38570343 | PMC:PMC10991018 | DOI:10.1007/s00432-024-05699-1
Source: Clin Med Res - Category: Research Authors: Ina Shehaj Slavomir Krajnak Morva Tahmasbi Rad Bahar Gasimli Annette Hasenburg Thomas Karn Marcus Schmidt Volker M üller Sven Becker Khayal Gasimli Source Type: research
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Endometrial Cancer | Hypertension | Metabolic Syndrome | Obesity | OBGYN | Research | Study